Wim H Kruit

Wim H Kruit

UNVERIFIED PROFILE

Are you Wim H Kruit?   Register this Author

Register author
Wim H Kruit

Wim H Kruit

Publications by authors named "Wim H Kruit"

Are you Wim H Kruit?   Register this Author

39Publications

792Reads

46Profile Views

Pimasertib-associated ophthalmological adverse events.

Acta Ophthalmol 2018 Nov 16;96(7):712-718. Epub 2018 Jan 16.

Department of Ophthalmology, Leiden University Medical Centre, Leiden, the Netherlands.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/aos.13677
Publisher Site
http://dx.doi.org/10.1111/aos.13677DOI Listing
November 2018

Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatment.

Eur J Cancer 2016 Mar 1;56:101-106. Epub 2016 Feb 1.

Dept of Medical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.12.019DOI Listing
March 2016

Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial.

J Clin Oncol 2013 Oct 9;31(30):3831-7. Epub 2013 Sep 9.

Alexander M.M. Eggermont, Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, and Université Paris-Sud, Kremlin Bicêtre, Paris, France; Stefan Suciu, Larissa Polders, and Michel Praet, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Jeremy Marsden, University Hospital Birmingham, Birmingham; Philippa Corrie, Addenbrookes Hospital, Cambridge; Poulam M. Patel, University of Nottingham, Nottingham; Neville Davidson, Broomfield Hospital, Broomfield, United Kingdom; Mario Santinami, Istituto Nazionale dei Tumori, Milan; Paolo A. Ascierto, Istituto Nazionale Tumori Fondazione Pascale, Napoli; Lorenzo Borgognoni, Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence; Maria Grazia Bernengo, University Hospital Turin, Turin, Italy; Steinar Aamdal, Oslo University Hospital and Radium Hospital, Oslo, Norway; Wim H. Kruit, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands; Lars Bastholt, Odense University Hospital, Odense, Denmark; and Alan Spatz, McGill University and Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.9303DOI Listing
October 2013

[Revision of the national guideline 'Melanoma'].

Ned Tijdschr Geneeskd 2013 ;157(12):A6136

Integraal Kankercentrum Nederland, afd. Richtlijnen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
May 2013

Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies--EORTC 18991.

J Clin Oncol 2010 May 12;28(14):2460-6. Epub 2010 Apr 12.

Department of Surgery, Division Surgical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.24.6264DOI Listing
May 2010

Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991).

Cancer Chemother Pharmacol 2010 Mar 21;65(4):671-7. Epub 2009 Jul 21.

Department of Surgical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, 310 Groene Hilledijk, 3075 EA, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-009-1072-zDOI Listing
March 2010

[Improved compliance with the 'Melanoma' treatment guideline].

Ned Tijdschr Geneeskd 2010 ;154:A858

Integraal Kankercentrum West, Leiden, afd. Kankerregistratie, The Netherlands.

View Article

Download full-text PDF

Source
March 2010

Interferon-alpha influences tryptophan metabolism without inducing psychiatric side effects.

Neuropsychobiology 2007 17;55(3-4):225-31. Epub 2007 Sep 17.

Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000108382DOI Listing
December 2007

Side effects of interferon-alpha therapy.

Pharm World Sci 2005 Dec;27(6):423-31

Department of Medical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, P.O. Box 5201, 3008, Rotterdam, AE, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11096-005-1319-7DOI Listing
December 2005

Platelet MAO activity during treatment with pegylated interferon-alfa in melanoma patients.

Prog Neuropsychopharmacol Biol Psychiatry 2005 Jan 18;29(1):109-14. Epub 2004 Nov 18.

Department of Psychiatry, Erasmus MC-Daniel den Hoed Cancer Center, P.O. Box 5201, 3008 AE Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pnpbp.2004.10.012DOI Listing
January 2005

Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant.

Cancer Immunol Immunother 2005 Jan;54(1):37-43

Department of Medical Oncology, Erasmus Medical Center, Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-004-0574-0
Publisher Site
http://dx.doi.org/10.1007/s00262-004-0574-0DOI Listing
January 2005

Thalidomide in solid tumours: the resurrection of an old drug.

Eur J Cancer 2004 Nov;40(16):2377-82

Department of Medical Oncology, Daniel den Hoed Cancer Center, Erasmus University Medical Center, Groene Hilledijk 301, EA Rotterdam 3075, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2004.07.023DOI Listing
November 2004

Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients.

Psychiatry Res 2003 Jul;119(1-2):125-32

Department of Psychosocial Oncology, Erasmus Medical Center - Daniel den Hoed Cancer Center, P.O. Box 5201, 3008 AE, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-1781(03)00113-6DOI Listing
July 2003

IL-12: a promising adjuvant for cancer vaccination.

Cancer Immunol Immunother 2003 Mar 12;52(3):133-44. Epub 2003 Feb 12.

Department of Medical Oncology, Erasmus Medical Center, Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-002-0356-5DOI Listing
March 2003

Neuropsychiatric side effects of interferon-alfa therapy.

Pharm World Sci 2003 Feb;25(1):11-20

Department of Psychosocial Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1022449613907DOI Listing
February 2003